Netherlands· NL-32aefb90be4d
Wilzin 50 mg, harde capsules
A zinc acetate product containing zinkdiacetaat 2-water (e 650), registered in Netherlands by Orphan Europe SARL. The same ATC class is registered in 9 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Zinc acetate is registered in 9 of 19 countries.
Countries holding a registration under ATC A16AX05 (zinc acetate), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Zinc acetate · ATC A16AX05
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ZINKDIACETAAT 2-WATER (E 650)
- Manufacturer
- Orphan Europe SARL
- Country
- Netherlands (NL)
- ATC code
- A16AX05
- ATC class
- Zinc acetate
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/04/286
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
124 interactions on record for zinc acetate.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zinc acetate · interactions on record
124 records
- 4 severe
- 31 moderate
- 89 minor
Most severe, free to view
- RaltegravirJ05AJ01severe
- ElvitegravirJ05AJ02severe
- RaltegravirJ05AX08severe
- ElvitegravirJ05AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A16AX05
Zinc acetate, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/683016a1-37c5-42d2-93a8-1d6e6572605a GET /v1/drugs/683016a1-37c5-42d2-93a8-1d6e6572605a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/wilzin-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Zinc Acetate",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71842",
"excipients": [
"AMMONIA (E 527)",
"GELATINE (E 441)",
"IJZEROXIDE ZWART (E 172)",
"KALIUMHYDROXIDE (E 525)",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"PROPYLEENGLYCOL (E 1520)",
"SCHELLAK (E 904)",
"TITAANDIOXIDE (E 171)",
"ZONNEGEEL FCF (E 110)",
"ZWARTE INKT"
],
"substances": [
"ZINKDIACETAAT 2-WATER (E 650)"
],
"leaflet_url": null,
"authorised_at": "2004/10/13",
"procedure_number": "EMEA/H/C/000535",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/04/286",
"additional_monitoring": "N"
}See everything about zinc acetate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.